Aurinia Pharmaceuticals Inc
NASDAQ:AUPH

Watchlist Manager
Aurinia Pharmaceuticals Inc Logo
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Watchlist
Price: 8.14 USD -1.45%
Market Cap: 1.2B USD
Have any thoughts about
Aurinia Pharmaceuticals Inc?
Write Note

Aurinia Pharmaceuticals Inc
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Aurinia Pharmaceuticals Inc
Additional Paid In Capital Peer Comparison

Comparables:
B
DRUG
TH
RPTX
COV
EDT

Competitive Additional Paid In Capital Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Additional Paid In Capital
$119.8m
CAGR 3-Years
30%
CAGR 5-Years
33%
CAGR 10-Years
26%
B
Bright Minds Biosciences Inc
CNSX:DRUG
Additional Paid In Capital
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Additional Paid In Capital
$24.6m
CAGR 3-Years
25%
CAGR 5-Years
21%
CAGR 10-Years
12%
Repare Therapeutics Inc
NASDAQ:RPTX
Additional Paid In Capital
$61.8m
CAGR 3-Years
119%
CAGR 5-Years
190%
CAGR 10-Years
N/A
Covalon Technologies Ltd
XTSX:COV
Additional Paid In Capital
CA$11.8m
CAGR 3-Years
0%
CAGR 5-Years
12%
CAGR 10-Years
18%
Spectral Medical Inc
TSX:EDT
Additional Paid In Capital
CA$10.1m
CAGR 3-Years
8%
CAGR 5-Years
5%
CAGR 10-Years
2%

See Also

What is Aurinia Pharmaceuticals Inc's Additional Paid In Capital?
Additional Paid In Capital
119.8m USD

Based on the financial report for Sep 30, 2024, Aurinia Pharmaceuticals Inc's Additional Paid In Capital amounts to 119.8m USD.

What is Aurinia Pharmaceuticals Inc's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 10Y
26%

Over the last year, the Additional Paid In Capital growth was 9%. The average annual Additional Paid In Capital growth rates for Aurinia Pharmaceuticals Inc have been 30% over the past three years , 33% over the past five years , and 26% over the past ten years .

Back to Top